According to the Centers for Disease Control (CDC) report, "Sexually Transmitted Disease Surveillance, 2009," there are approximately 19 million new STD infections each year, which cost the U.S. healthcare system $16.4 billion annually and cost individuals even more in terms of acute and long-term health consequences.
The data are based on state and local STD case reports from a variety of private and public sources, the majority of which come from non-STD clinic settings, such as private physicians and health maintenance organizations.
Sexually transmitted diseases (STDs) remain a major public health challenge in the U.S. CDCs surveillance report includes data on the three STDs that physicians are required to report to the agency chlamydia, gonorrhea and syphilis which represent only a fraction of the true burden of STDs. Some common STDs, such as human papillomavirus (HPV) and genital herpes, are not reported to CDC.
Despite the continued high burden of STDs, the latest CDC data show some signs of progress:
- Gonorrhea: The national gonorrhea rate is at the lowest level ever recorded.
- Chlamydia: Continuing increases in chlamydia diagnoses likely reflect expanded screening efforts, and not necessarily a true increase in disease burden; this means that more people are protecting their health by getting tested and being linked to treatment. This is critical, since chlamydia is one of the most widespread STDs in the United States.
- Syphilis: For the first time in five years, reported syphilis cases did not increase among women overall. Likewise, cases of congenital syphilis (transmitted from mother to infant) did not increase for the first time in four years.
Yet, there are large disparities by race and age. CDC surveillance data show much higher rates of reported STDs among some racial or ethnic minority groups than among whites. This is consistent with other data sources showing marked STD disparities in some minority populations. A range of factors contributes to these disparities, including poverty, lack of access to health care and an already high prevalence of STDs in communities of color that increases a persons risk of infection with each sexual encounter. And regardless of race or gender, data show that sexually active adolescents and young adults are at increased risk for STDs when compared to older adults. Acknowledging disparities in STD rates is one of the first steps in empowering affected communities to focus on the problem and helping the public health community direct prevention and treatment resources appropriately.
Less than half of people who should be screened receive recommended STD screening services. Undetected and untreated STDs can increase a persons risk for HIV and cause other serious health consequences, such as infertility. STD screening can help detect disease early and, when combined with treatment, is one of the most effective tools available to protect ones health and prevent the spread of STDs to others.
Untreated gonorrhea and chlamydia can result in pelvic inflammatory disease in women, a condition that can cause infertility. Each year, STDs cause at least 24,000 women in the U.S. to become infertile. Untreated syphilis can lead to serious long-term complications, including brain, cardiovascular and organ damage. Syphilis in pregnant women can also result in congenital syphilis (syphilis among infants), which can cause stillbirth, death soon after birth, and physical deformity and neurological complications in children who survive. Untreated syphilis in pregnant women results in infant death in up to 40 percent of cases. Studies suggest that people with gonorrhea, chlamydia or syphilis are at increased risk for HIV. This is especially concerning for young black men, among whom the rate of syphilis is increasing.
Redefining Competency: A Comprehensive Framework for Infection Preventionists
December 19th 2024Explore APIC’s groundbreaking framework for defining and documenting infection preventionist competency. Christine Zirges, DNP, ACNS-BC, CIC, FAPIC, shares insights on advancing professional growth, improving patient safety, and navigating regulatory challenges.
Addressing Post-COVID Challenges: The Urgent Need for Enhanced Hospital Reporting Metrics
December 18th 2024Explore why CMS must expand COVID-19, influenza, and RSV reporting to include hospital-onset infections, health care worker cases, and ER trends, driving proactive prevention and patient safety.
Announcing the 2024 Infection Control Today Educator of the Year: Shahbaz Salehi, MD, MPH, MSHIA
December 17th 2024Shahbaz Salehi, MD, MPH, MSHIA, is the Infection Control Today 2024 Educator of the Year. He is celebrated for his leadership, mentorship, and transformative contributions to infection prevention education and patient safety.
Pula General Hospital Celebrates Clean Hospitals
December 16th 2024Learn how Pula General Hospital in Croatia championed infection prevention and environmental hygiene and celebrated Clean Hospitals Day to honor cleaning staff and promote advanced practices for exceptional patient care and safety.
Understanding NHSN's 2022 Rebaseline Data: Key Updates and Implications for HAI Reporting
December 13th 2024Discover how the NHSN 2022 Rebaseline initiative updates health care-associated infection metrics to align with modern health care trends, enabling improved infection prevention strategies and patient safety outcomes.